{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T06:02:35Z","timestamp":1789624955058,"version":"build-2803163510"},"reference-count":92,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,7,15]],"date-time":"2023-07-15T00:00:00Z","timestamp":1689379200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,7,15]],"date-time":"2023-07-15T00:00:00Z","timestamp":1689379200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Orthop Traumatol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>This joint report from the Italian Society of Orthopaedics and Traumatology (SIOT) and the Italian Society of Periodontology and Implantology (SIdP) aims for a consensus around the scientific rationale and clinical strategy for the management of osteoporotic patients affected by periodontitis who are undergoing anti-resorptive (AR) therapy to manage the risk of the occurrence of a medication-related osteonecrosis of the jaws (MRONJ). Osteoporosis and periodontitis are chronic diseases with a high prevalence in aging patients, and they share some of the same pathogenetic mechanisms based upon inflammation. Available evidence shows the relationship among osteoporosis, AR agents, periodontitis and implant therapy in relation to the incidence of MRONJ. Uncontrolled periodontitis may lead to tooth loss and to the need to replace teeth with dental implants. Tooth extraction and surgical dental procedures are recognized as the main risk factors for developing MRONJ in individuals taking AR therapy for osteometabolic conditions. Although the incidence of MRONJ in osteometabolic patients taking AR therapy may be as low as 0.9%, the increasing prevalence of osteoporosis and the high prevalence of periodontitis suggest that this potential complication should not be overlooked. Good clinical practice (GCP) guidelines are proposed that aim at a more integrated approach (prescriber, dentist, periodontist and dental hygienist) in the management of periodontitis patients undergoing AR therapy for osteometabolic disorders to reduce the risk of MRONJ. Dental professional and prescribers should educate patients regarding the potential risk associated with the long-term use of AR therapy and oral health behavior.<\/jats:p>","DOI":"10.1186\/s10195-023-00713-7","type":"journal-article","created":{"date-parts":[[2023,7,15]],"date-time":"2023-07-15T17:01:40Z","timestamp":1689440500000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Anti-resorptive therapy in the osteometabolic patient affected by periodontitis. A joint position paper of the Italian Society of Orthopaedics and Traumatology (SIOT) and the Italian Society of Periodontology and Implantology (SIdP)"],"prefix":"10.1186","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8548-4395","authenticated-orcid":false,"given":"L.","family":"Landi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. Tranquilli","family":"Leali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Barbato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. M.","family":"Carrassi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Discepoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. C. M.","family":"Muti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Oteri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Rigoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Romanini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Ruggiero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"U.","family":"Tarantino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Varoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N. M.","family":"Sforza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. L.","family":"Brandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,7,15]]},"reference":[{"issue":"4","key":"713_CR1","doi-asserted-by":"publisher","first-page":"323","DOI":"10.4248\/BR201304003","volume":"1","author":"S Adami","year":"2013","unstructured":"Adami S, Idolazzi L, Fracassi E, Gatti D, Rossini M (2013) Osteoporosis treatment: when to discontinue and when to re-start. Bone Res 1(4):323\u2013335. https:\/\/doi.org\/10.4248\/BR201304003","journal-title":"Bone Res"},{"issue":"5","key":"713_CR2","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1016\/j.joms.2009.10.010","volume":"68","author":"TL Aghaloo","year":"2010","unstructured":"Aghaloo TL, Felsenfeld AL, Tetradis S (2010) Osteonecrosis of the jaw in a patient on Denosumab. J Oral Maxillofac Surg 68(5):959\u2013963. https:\/\/doi.org\/10.1016\/j.joms.2009.10.010","journal-title":"J Oral Maxillofac Surg"},{"issue":"8","key":"713_CR3","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.1002\/jbmr.379","volume":"26","author":"TL Aghaloo","year":"2011","unstructured":"Aghaloo TL, Kang B, Sung EC, Shoff M, Ronconi M, Gotcher JE, Tetradis S (2011) Periodontal disease and bisphosphonates induce osteonecrosis of the jaws in the rat. J Bone Min Res. 26(8):1871\u201382. https:\/\/doi.org\/10.1002\/jbmr.379","journal-title":"J Bone Min Res."},{"key":"713_CR4","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/j.coms.2015.06.001","volume":"27","author":"T Aghaloo","year":"2015","unstructured":"Aghaloo T, Hazboun R, Tetradis S (2015) Pathophysiology of osteonecrosis of the jaws. Oral Maxillofac Surg Clin North Am 27:489. https:\/\/doi.org\/10.1016\/j.coms.2015.06.001","journal-title":"Oral Maxillofac Surg Clin North Am"},{"issue":"7","key":"713_CR5","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1111\/jcpe.12420","volume":"42","author":"M Aimetti","year":"2015","unstructured":"Aimetti M, Perotto S, Castiglione A, Mariani GM, Ferrarotti F, Romano F (2015) Prevalence of periodontitis in an adult population from an urban area in North Italy: findings from a cross-sectional population-based epidemiological survey. J Clin Periodontol 42(7):622\u2013631. https:\/\/doi.org\/10.1111\/jcpe.12420","journal-title":"J Clin Periodontol"},{"key":"713_CR6","unstructured":"Amgen Inc. (2020) Prolia (denosumab): investigator\u2019s brochure. Amgen Inc., Thousand Oaks"},{"issue":"5","key":"713_CR7","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1210\/clinem\/dgab888","volume":"107","author":"AD Anastasilakis","year":"2022","unstructured":"Anastasilakis AD, Pepe J, Napoli N, Palermo A, Magopoulos C, Khan AA, Zillikens MC, Body JJ (2022) Osteonecrosis of the jaw and antiresorptive agents in benign and malignant diseases: a critical review organized by the ECTS. J Clin Endocrinol Metab. 107(5):1441\u20131460. https:\/\/doi.org\/10.1210\/clinem\/dgab888","journal-title":"J Clin Endocrinol Metab."},{"key":"713_CR8","doi-asserted-by":"publisher","first-page":"2396","DOI":"10.1056\/NEJMoa1005361","volume":"363","author":"JD Bashutski","year":"2010","unstructured":"Bashutski JD, Eber RM, Kinney JS, Benavides E, Maitra S, Braun TM, Giannobile WV, McCauley LK (2010) Teriparatide and osseous regeneration in the oral cavity. N Engl J Med 363:2396\u20132405. https:\/\/doi.org\/10.1056\/NEJMoa1005361","journal-title":"N Engl J Med"},{"key":"713_CR9","doi-asserted-by":"publisher","unstructured":"Black DM, Rosen CJ (2016) Clinical practice postmenopausal osteoporosis. New Engl J Med. 374(3):254\u201362. https:\/\/doi.org\/10.1056\/NEJMcp1513724","DOI":"10.1056\/NEJMcp1513724"},{"issue":"4","key":"713_CR10","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1016\/j.jcms.2015.02.018","volume":"43","author":"JP Bodem","year":"2015","unstructured":"Bodem JP, Kargus S, Eckstein S, Saure D, Engel M, Hoffmann J, Freudlsperger C (2015) Incidence of bisphosphonate-related osteonecrosis of the jaw in high-risk patients undergoing surgical tooth extraction. J Cranio-Maxillofac Surg 43(4):510\u2013514. https:\/\/doi.org\/10.1016\/j.jcms.2015.02.018","journal-title":"J Cranio-Maxillofac Surg"},{"issue":"3","key":"713_CR11","doi-asserted-by":"publisher","first-page":"217","DOI":"10.2334\/josnusd.21-0016","volume":"63","author":"M Cabras","year":"2021","unstructured":"Cabras M, Gambino A, Broccoletti R, Sciascia S, Arduino PG (2021) Lack of evidence in reducing risk of MRONJ after teeth extractions with systemic antibiotics. J Oral Sci 63(3):217\u2013226. https:\/\/doi.org\/10.2334\/josnusd.21-0016","journal-title":"J Oral Sci"},{"key":"713_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4158\/GL-2020-0524SUPPL","volume":"26","author":"PM Camacho","year":"2020","unstructured":"Camacho PM, Petak SM, Binkley N, Diab DL, Eldeiry LS, Farooki A, Watts NB (2020) American Association of Clinical Endocrinologists\/American College of Endocrinology Clinical Practice Guidelines for the Diagnosis and Treatment of Postmenopausal Osteoporosis\u20142020 Update. Endocr Pract 26:1\u201346. https:\/\/doi.org\/10.4158\/GL-2020-0524SUPPL","journal-title":"Endocr Pract"},{"key":"713_CR13","volume-title":"Raccomandazioni clinico-terapeutiche sull\u2019osteonecrosi delle ossa mascellari (ONJ) farmaco-relata e sua prevenzione","author":"G Campisi","year":"2020","unstructured":"Campisi G, Bedogni A, Fusco V (2020) Raccomandazioni clinico-terapeutiche sull\u2019osteonecrosi delle ossa mascellari (ONJ) farmaco-relata e sua prevenzione, 2nd edn. Palermo University Press, Palermo","edition":"2"},{"issue":"1","key":"713_CR14","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s13005-021-00280-4","volume":"17","author":"G Campisi","year":"2021","unstructured":"Campisi G, Mauceri R, Bertoldo F, Fusco V, Bedogni A (2021) A pragmatic window of opportunity to minimise the risk of MRONJ development in individuals with osteoporosis on Denosumab therapy: a hypothesis. Head Face Med 17(1):25. https:\/\/doi.org\/10.1186\/s13005-021-00280-4","journal-title":"Head Face Med"},{"key":"713_CR15","doi-asserted-by":"publisher","unstructured":"Campisi G, Mauceri R, Bertoldo F, Bettini G, Biasotto M, Colella G, Consolo U, Di Fede O, Favia G, Fusco V, Gabriele M, Lo Casto A, Lo Muzio L, Marcian\u00f2 A, Mascitti M, Meleti M, Mignogna MD, Oteri G, Panzarella V, Romeo U, Santarelli A, Vescovi P, Marchetti C, Bedogni A (2020) Medication-related osteonecrosis of jaws (MRONJ) prevention and diagnosis: Italian consensus update 2020. Int J Environ Res Public Health 17(16):5998. https:\/\/doi.org\/10.3390\/ijerph17165998","DOI":"10.3390\/ijerph17165998"},{"key":"713_CR16","doi-asserted-by":"publisher","first-page":"115866","DOI":"10.1016\/j.bone.2021.115866","volume":"145","author":"EJ Castillo","year":"2021","unstructured":"Castillo EJ, Messer JG, Abraham AM, Jiron JM, Alekseyenko AV, Israel R, Aguirre JI (2021) Preventing or controlling periodontitis reduces the occurrence of osteonecrosis of the jaw (ONJ) in rice rats (Oryzomys Palustris). Bone 145:115866. https:\/\/doi.org\/10.1016\/j.bone.2021.115866","journal-title":"Bone"},{"key":"713_CR17","doi-asserted-by":"publisher","unstructured":"Center JR, Lyles KW, Bliuc D (2020) Bisphosphonates and lifespan. Bone 141:115566. https:\/\/doi.org\/10.1016\/j.bone.2020.115566","DOI":"10.1016\/j.bone.2020.115566"},{"key":"713_CR18","doi-asserted-by":"publisher","unstructured":"Chapple ILC, Bouchard P, Cagetti MG, Campus G, Carra M-C, Cocco F, Schulte AG (2017) Interaction of lifestyle, behaviour or systemic diseases with dental caries and periodontal diseases: consensus report of group 2 of the Joint EFP\/ORCA Workshop on the Boundaries Between Caries and Periodontal Diseases. J Clin Periodontol. 44:S39-51. https:\/\/doi.org\/10.1111\/jcpe.12685","DOI":"10.1111\/jcpe.12685"},{"key":"713_CR19","doi-asserted-by":"publisher","first-page":"S71","DOI":"10.1111\/jcpe.12366","volume":"42","author":"ILC Chapple","year":"2015","unstructured":"Chapple ILC, Van der Weijden F, Doerfer C, Herrera D, Shapira L, Polak D, Graziani F (2015) Primary prevention of periodontitis: managing gingivitis. J Clin Periodontol. 42:S71-76. https:\/\/doi.org\/10.1111\/jcpe.12366","journal-title":"J Clin Periodontol."},{"issue":"9","key":"713_CR20","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1002\/jbmr.3735","volume":"34","author":"P Chavassieux","year":"2019","unstructured":"Chavassieux P, Chapurlat R, Portero-Muzy N, Roux J-P, Garcia P, Grauer JP, Brown A (2019) Bone-forming and antiresorptive effects of Romosozumab in postmenopausal women with osteoporosis: bone histomorphometry and microcomputed tomography analysis after 2 and 12 months of treatment. J Bone Min Res. 34(9):1597\u20131608. https:\/\/doi.org\/10.1002\/jbmr.3735","journal-title":"J Bone Min Res."},{"key":"713_CR21","doi-asserted-by":"publisher","unstructured":"Chen MX, Zhong YJ, Dong QQ, Wong HM, Wen YF (2021) Global, regional, and national burden of severe periodontitis, 1990\u20132019: an Analysis of the Global Burden of Disease Study 2019. J Clin Periodontol 48(9):1165\u20131188. https:\/\/doi.org\/10.1111\/jcpe.13506","DOI":"10.1111\/jcpe.13506"},{"issue":"2","key":"713_CR22","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1002\/jbmr.3337","volume":"33","author":"SR Cummings","year":"2018","unstructured":"Cummings SR, Ferrari S, Eastell R, Gilchrist N, Jensen JEB, McClung M et al (2018) Vertebral fractures after discontinuation of Denosumab: a post hoc analysis of the randomized placebo-controlled FREEDOM trial and its extension. J Bone Miner Res 33(2):190\u2013198. https:\/\/doi.org\/10.1002\/jbmr.3337","journal-title":"J Bone Miner Res"},{"issue":"2","key":"713_CR23","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1177\/154405910408300214","volume":"83","author":"F D\u2019Aiuto","year":"2004","unstructured":"D\u2019Aiuto F, Parkar M, Andreou G, Suvan J, Brett PM, Ready D, Tonetti MS (2004) Periodontitis and systemic inflammation: control of the local infection is associated with a reduction in serum inflammatory markers. J Dent Res 83(2):156\u2013160. https:\/\/doi.org\/10.1177\/154405910408300214","journal-title":"J Dent Res"},{"key":"713_CR24","doi-asserted-by":"publisher","unstructured":"Dicembrini I, Serni L, Monami M, Caliri M, Barbato L, Cairo F, Mannucci E (2020) Type 1 diabetes and periodontitis: prevalence and periodontal destruction\u2014a systematic review. Acta Diabetol 57(12):1405\u20131412. https:\/\/doi.org\/10.1007\/s00592-020-01531-7","DOI":"10.1007\/s00592-020-01531-7"},{"key":"713_CR25","doi-asserted-by":"publisher","first-page":"116289","DOI":"10.1016\/j.bone.2021.116289","volume":"156","author":"FH Ebetino","year":"2022","unstructured":"Ebetino FH, Sun S, Cherian P, Roshandel S, Neighbors JD, Hu E, Russell RGG (2022) Bisphosphonates: the role of chemistry in understanding their biological actions and structure-activity relationships, and new directions for their therapeutic use. Bone 156:116289. https:\/\/doi.org\/10.1016\/j.bone.2021.116289","journal-title":"Bone"},{"issue":"1","key":"713_CR26","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1111\/prd.12323","volume":"82","author":"PI Eke","year":"2020","unstructured":"Eke PI, Borgnakke WS, Genco RJ (2020) Recent epidemiologic trends in periodontitis in the USA. Periodontology 2000 82(1):257\u201367. https:\/\/doi.org\/10.1111\/prd.12323","journal-title":"Periodontology 2000"},{"issue":"1","key":"713_CR27","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s11657-016-0292-1","volume":"11","author":"S Ferrari","year":"2016","unstructured":"Ferrari S, Reginster J-Y, Brandi ML, Kanis JA, Devogelaer J-P, Kaufman J-M, Rizzoli R (2016) Unmet needs and current and future approaches for osteoporotic patients at high risk of hip fracture. Arch Osteoporos. 11(1):37. https:\/\/doi.org\/10.1007\/s11657-016-0292-1","journal-title":"Arch Osteoporos."},{"key":"713_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00774-020-01089-y","volume":"38","author":"Y Fujieda","year":"2020","unstructured":"Fujieda Y, Doi M, Asaka T, Ota M, Hisada R, Ohnishi N, Kono M, Kameda H, Nakazawa D, Kato M et al (2020) Incidence and risk of antiresorptive agent-related osteonecrosis of the jaw (ARONJ) after tooth extraction in patients with autoimmune disease. J Bone Miner Metab 38:1\u20138. https:\/\/doi.org\/10.1007\/s00774-020-01089-y","journal-title":"J Bone Miner Metab"},{"issue":"2","key":"713_CR29","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1002\/jbmr.4472","volume":"37","author":"J Everts-Graber","year":"2022","unstructured":"Everts-Graber J, Lehmann D, Burkard JP, Schaller B, Gahl B, H\u00e4uselmann H, Studer U, Ziswiler HR, Reichenbach S, Lehmann T (2022) Risk of osteonecrosis of the jaw under Denosumab compared to bisphosphonates in patients with osteoporosis. J Bone Miner Res. 37(2):340\u2013348. https:\/\/doi.org\/10.1002\/jbmr.4472","journal-title":"J Bone Miner Res."},{"key":"713_CR30","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1111\/jcpe.12455","volume":"42","author":"E Gaudin","year":"2015","unstructured":"Gaudin E, Seidel L, Bacevic M, Rompen E, Lambert F (2015) Occurrence and risk indicators of medication-related osteonecrosis of the jaw after dental extraction: a systematic review and meta-analysis. J Clin Periodontol 42:922\u2013932. https:\/\/doi.org\/10.1111\/jcpe.12455","journal-title":"J Clin Periodontol"},{"key":"713_CR31","doi-asserted-by":"publisher","DOI":"10.1097\/SCS.0000000000002564","author":"I Giovannacci","year":"2016","unstructured":"Giovannacci I, Meleti M, Manfredi M, Mortellaro C, Greco LA, Bonanini M, Vescovi P (2016) Medication-related osteonecrosis of the jaw around dental implants. J Craniofac Surg. https:\/\/doi.org\/10.1097\/SCS.0000000000002564","journal-title":"J Craniofac Surg"},{"key":"713_CR32","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.bone.2019.03.031","volume":"123","author":"I Gkouveris","year":"2019","unstructured":"Gkouveris I, Hadaya D, Soundia A, Bezouglaia O, Chau Y, Dry SM, Tetradis S (2019) Vasculature submucosal changes at early stages of osteonecrosis of the jaw (ONJ). Bone 123:234\u201345. https:\/\/doi.org\/10.1016\/j.bone.2019.03.031","journal-title":"Bone"},{"issue":"2","key":"713_CR33","doi-asserted-by":"publisher","first-page":"e195","DOI":"10.4317\/medoral.22691","volume":"24","author":"A Granate-Marques","year":"2019","unstructured":"Granate-Marques A, Polis-Yanes C, Seminario-Amez M, Jane-Salas E, Lopez-Lopez J (2019) Medication-related osteonecrosis of the jaw associated with implant and regenerative treatments: systematic review. Medicina Oral Patolog\u00eda Oral y Cirugia Bucal 24(2):e195\u2013e203. https:\/\/doi.org\/10.4317\/medoral.22691","journal-title":"Medicina Oral Patolog\u00eda Oral y Cirugia Bucal"},{"key":"713_CR34","doi-asserted-by":"publisher","unstructured":"Grbic JT, Black DM, Lyles KW, Reid DW, Orwoll E, McClung M, Bucci-Rechtweg C, Guoqin Su (2010) The incidence of osteonecrosis of the jaw in patients receiving 5 milligrams of zoledronic acid data from the Health Outcomes and Reduced Incidence with Zoledronic Acid Once Yearly clinical trials program. J Am Dent Ass. 141(11):1365\u20131370. https:\/\/doi.org\/10.14219\/jada.archive.2010.0082","DOI":"10.14219\/jada.archive.2010.0082"},{"key":"713_CR35","doi-asserted-by":"crossref","unstructured":"Hallmer F, Andersson G, Gotrick B et al (2018) Prevalence, initiating factor, and treatment outcome of medication-related osteonecrosis of the jaw\u2014a 4-year prospective study. Oral Surg Oral Med Oral Pathol Oral Radiol 126:477","DOI":"10.1016\/j.oooo.2018.08.015"},{"issue":"7","key":"713_CR36","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1038\/s41577-020-00488-6","volume":"21","author":"G Hajishengallis","year":"2021","unstructured":"Hajishengallis G, Chavakis T (2021) Local and systemic mechanisms linking periodontal disease and inflammatory comorbidities. Nat Rev Immunol 21(7):426\u2013440. https:\/\/doi.org\/10.1038\/s41577-020-00488-6","journal-title":"Nat Rev Immunol"},{"issue":"8","key":"713_CR37","doi-asserted-by":"publisher","first-page":"2465","DOI":"10.1007\/s00198-017-4063-7","volume":"28","author":"T Hasegawa","year":"2017","unstructured":"Hasegawa T, Kawakita A, Ueda N, Funahara R, Tachibana A, Kobayashi M, Kondou E, Takeda D, Kojima Y, Sato S, Yanamoto S, Komatsubara H, Umeda M, Kirita T, Kurita H, Shibuya Y, Komori T (2017) A multicenter retrospective study of the risk factors associated with medication-related osteonecrosis of the jaw after tooth extraction in patients receiving oral bisphosphonate therapy: can primary wound closure and a drug holiday really prevent MRONJ? Osteoporos Int. 28(8):2465\u20132473. https:\/\/doi.org\/10.1007\/s00198-017-4063-7","journal-title":"Osteoporos Int."},{"key":"713_CR38","doi-asserted-by":"publisher","unstructured":"Herrera D, Sanz M, Kebschull M, Jepsen S, Sculean A, Berglundh T, Kopp I (2022) Treatment of stage IV periodontitis: the EFP S3 level clinical practice guideline. J Clin Periodontol 49(S24):4\u201371. https:\/\/doi.org\/10.1111\/jcpe.13639","DOI":"10.1111\/jcpe.13639"},{"issue":"12","key":"713_CR39","doi-asserted-by":"publisher","first-page":"1726","DOI":"10.1007\/s00198-006-0172-4","volume":"17","author":"O Johnell","year":"2006","unstructured":"Johnell O, Kanis JA (2006) An estimate of the worldwide prevalence and disability associated with osteoporotic fractures. Osteoporos Int 17(12):1726\u20131733. https:\/\/doi.org\/10.1007\/s00198-006-0172-4","journal-title":"Osteoporos Int"},{"issue":"4","key":"713_CR40","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1177\/0022034515572021","volume":"94","author":"H Katsarelis","year":"2015","unstructured":"Katsarelis H, Shah NP, Dhariwal DK, Pazianas M (2015) Infection and medication-related osteonecrosis of the jaw. J Dent Res 94(4):534\u2013539. https:\/\/doi.org\/10.1177\/0022034515572021","journal-title":"J Dent Res"},{"issue":"1","key":"713_CR41","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1007\/s12325-021-01936-y","volume":"39","author":"DL Kendler","year":"2022","unstructured":"Kendler DL, Cosman F, Stad RK, Ferrari S (2022) Denosumab in the treatment of osteoporosis: 10 years later: a narrative review. Adv Ther 39(1):58\u201374. https:\/\/doi.org\/10.1007\/s12325-021-01936-y","journal-title":"Adv Ther"},{"issue":"6","key":"713_CR42","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1007\/s11914-022-00756-5","volume":"20","author":"AS Kim","year":"2022","unstructured":"Kim AS, Girgis CM, McDonald MM (2022) Osteoclast recycling and the rebound phenomenon following denosumab discontinuation. Curr Osteoporos Rep 20(6):505\u2013515. https:\/\/doi.org\/10.1007\/s11914-022-00756-5","journal-title":"Curr Osteoporos Rep"},{"issue":"4","key":"713_CR43","doi-asserted-by":"publisher","first-page":"41","DOI":"10.3390\/dj4040041","volume":"4","author":"YD Kwon","year":"2016","unstructured":"Kwon YD, Kim DY (2016) Role of teriparatide in medication-related osteonecrosis of the jaws (MRONJ). Dent J (Basel). 4(4):41. https:\/\/doi.org\/10.3390\/dj4040041","journal-title":"Dent J (Basel)."},{"issue":"5","key":"713_CR44","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1016\/j.bone.2009.07.011","volume":"45","author":"P Lesclous","year":"2009","unstructured":"Lesclous P, Najm SA, Carrel J-P, Baroukh B, Lombardi T, Willi J-P, Samson J (2009) Bisphosphonate-associated osteonecrosis of the jaw: a key role of inflammation? Bone 45(5):843\u201352. https:\/\/doi.org\/10.1016\/j.bone.2009.07.011","journal-title":"Bone"},{"key":"713_CR45","unstructured":"Li Y, Lee S, Hujoel P, Su M, Zhang W, Kim J, Devizio W (2010) Prevalence and severity of gingivitis in American adults. Am J Dent. 23(1):9\u201313"},{"issue":"2","key":"713_CR46","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.joms.2009.03.050","volume":"68","author":"JC Lo","year":"2010","unstructured":"Lo JC, O\u2019Ryan FS, Gordon NP, Yang J, Hui RL, Martin D, Go AS (2010) Prevalence of osteonecrosis of the jaw in patients with oral bisphosphonate exposure. J Oral Maxillofacial Surg. 68(2):243\u2013253. https:\/\/doi.org\/10.1016\/j.joms.2009.03.050","journal-title":"J Oral Maxillofacial Surg."},{"issue":"1","key":"713_CR47","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1111\/prd.12297","volume":"83","author":"BG Loos","year":"2020","unstructured":"Loos BG, Van Dyke TE (2020) The role of inflammation and genetics in periodontal disease. Periodontology. 83(1):26\u201339. https:\/\/doi.org\/10.1111\/prd.12297","journal-title":"Periodontology."},{"key":"713_CR48","doi-asserted-by":"publisher","unstructured":"Lorenzo-Pouso AI, P\u00e9rez-Say\u00e1ns M, Chamorro-Petronacci C, G\u00e1ndara-Vila P, L\u00f3pez-Jornet P, Carballo J, Garc\u00eda-Garc\u00eda A (2020) Association between periodontitis and medication-related osteonecrosis of the jaw: a systematic review and meta-analysis. J Oral Pathol Med 49(3):190\u2013200. https:\/\/doi.org\/10.1111\/jop.12963","DOI":"10.1111\/jop.12963"},{"issue":"9","key":"713_CR49","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1016\/S0278-2391(03)00720-1","volume":"61","author":"RE Marx","year":"2003","unstructured":"Marx RE (2003) Pamidronate (Aredia) and Zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic. J Oral Maxillofac Surg 61(9):1115\u20131117. https:\/\/doi.org\/10.1016\/S0278-2391(03)00720-1","journal-title":"J Oral Maxillofac Surg"},{"issue":"8","key":"713_CR50","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1056\/NEJMoa044459","volume":"354","author":"MR McClung","year":"2006","unstructured":"McClung MR, Michael Lewiecki E, Cohen SB, Bolognese MA, Woodson GC, Moffett AH et al (2006) Denosumab in postmenopausal women with low bone mineral density. N Engl J Med 354(8):821\u2013831. https:\/\/doi.org\/10.1056\/NEJMoa044459","journal-title":"N Engl J Med"},{"key":"713_CR51","doi-asserted-by":"publisher","unstructured":"Morales A, Strauss FJ, H\u00e4mmerle CHF, Romandini M, Cavalla F, Baeza M, Gamonal J (2022) Performance of the 2017 AAP\/EFP case definition compared with the CDC\/AAP definition in population-based studies. J Periodontol. 93(7):1003\u201313. https:\/\/doi.org\/10.1002\/JPER.21-0276","DOI":"10.1002\/JPER.21-0276"},{"issue":"2","key":"713_CR52","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1111\/j.1754-4505.2009.00128.x","volume":"30","author":"P Narongroeknawin","year":"2010","unstructured":"Narongroeknawin P, Danila MI, Humphreys LG Jr, Barasch A, Curtis JR (2010) Bisphosphonate-associated osteonecrosis of the jaw, with healing after teriparatide: a review of the literature and a case report. Spec Care Dentist 30(2):77\u201382. https:\/\/doi.org\/10.1111\/j.1754-4505.2009.00128.x","journal-title":"Spec Care Dentist"},{"issue":"11","key":"713_CR53","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1111\/j.1600-051X.2007.01133.x.+","volume":"34","author":"L Nibali","year":"2007","unstructured":"Nibali L, D\u2019Aiuto F, Griffiths G, Patel K, Suvan J, Tonetti MS (2007) Severe periodontitis is associated with systemic inflammation and a dysmetabolic status: a case-control study. J Clin Periodontol 34(11):931\u2013937. https:\/\/doi.org\/10.1111\/j.1600-051X.2007.01133.x.+","journal-title":"J Clin Periodontol"},{"issue":"2","key":"713_CR54","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.oooo.2018.09.008","volume":"127","author":"O Nicolatou-Galitis","year":"2019","unstructured":"Nicolatou-Galitis O, Schi\u00f8dt M, Mendes RA, Ripamonti C, Hope S, Drudge-Coates L, Niepel D, Van den Wyngaert T (2019) Medication-related osteonecrosis of the jaw: definition and best practice for prevention, diagnosis, and treatment. Oral Surg Oral Med Oral Pathol Oral Radiol. 127(2):117\u2013135. https:\/\/doi.org\/10.1016\/j.oooo.2018.09.008","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol."},{"issue":"1","key":"713_CR55","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/s11739-018-1874-2","volume":"14","author":"R Nuti","year":"2019","unstructured":"Nuti R, Brandi ML, Checchia G, Di Munno O, Dominguez L, Falaschi P, Isaia GC (2019) Guidelines for the management of osteoporosis and fragility fractures. Int Emerg Med. 14(1):85\u2013102. https:\/\/doi.org\/10.1007\/s11739-018-1874-2","journal-title":"Int Emerg Med."},{"key":"713_CR56","doi-asserted-by":"publisher","DOI":"10.1038\/s41432-021-0196-9","author":"B Owen","year":"2021","unstructured":"Owen B, Bradley H (2021) Is it safe to place implants in patients at risk of MRONJ? Evid-Based Dent. https:\/\/doi.org\/10.1038\/s41432-021-0196-9","journal-title":"Evid-Based Dent"},{"issue":"4","key":"713_CR57","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/s10006-012-0379-9","volume":"17","author":"D Pakosch","year":"2013","unstructured":"Pakosch D, Papadimas D, Munding J, Kawa D, Kriwalsky MS (2013) Osteonecrosis of the mandible due to anti-angiogenic agent Bevacizumab. Oral Maxillofac Surg 17(4):303\u2013306. https:\/\/doi.org\/10.1007\/s10006-012-0379-9","journal-title":"Oral Maxillofac Surg"},{"key":"713_CR58","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1002\/jbmr.1479","volume":"27","author":"S Papapoulos","year":"2012","unstructured":"Papapoulos S, Chapurlat R, Libanati C, Brandi ML, Brown JP, Czerwi\u0144ski E, Krieg M-A, Man Z, Mellstr\u00f6m D, Radominski SC, Reginster J-Y, Resch H, Ivorra JAR, Roux C, Vittinghoff E, Austin M, Daizadeh N, Bradley MN, Grauer A, Cummings SR, Bone HG (2012) Five years of denosumab exposure in women with postmenopausal osteoporosis: results from the first two years of the FREEDOM extension. J Bone Miner Res 27:694\u2013701. https:\/\/doi.org\/10.1002\/jbmr.1479","journal-title":"J Bone Miner Res"},{"key":"713_CR59","doi-asserted-by":"publisher","unstructured":"Papapanou PN, Sanz M, Buduneli N, Dietrich T, Feres M, Fine DH, Tonetti MS (2018) Periodontitis: consensus report of workgroup 2 of the 2017 World Workshop on the Classification of Periodontal and Peri-implant Diseases and Conditions: classification and case definitions for periodontitis. J Clin Periodontol 45:S162-70. https:\/\/doi.org\/10.1111\/jcpe.12946","DOI":"10.1111\/jcpe.12946"},{"issue":"12","key":"713_CR60","doi-asserted-by":"publisher","first-page":"2587","DOI":"10.1007\/s40520-020-01497-0","volume":"32","author":"P Piscitelli","year":"2020","unstructured":"Piscitelli P, Neglia C, Feola M, Rizzo E, Argentiero A, Ascolese M, Tarantino U (2020) Updated incidence and costs of hip fractures in elderly Italian population. Aging Clin Exp Res. 32(12):2587\u201393. https:\/\/doi.org\/10.1007\/s40520-020-01497-0","journal-title":"Aging Clin Exp Res."},{"issue":"7","key":"713_CR61","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1111\/jcpe.13642","volume":"49","author":"V Pitchika","year":"2022","unstructured":"Pitchika V, Jordan RA, Norderyd O, Rolander B, Welk A, V\u00f6lzke H, Kocher T (2022) Factors influencing tooth loss in European populations. J Clin Periodontol. 49(7):642\u201353. https:\/\/doi.org\/10.1111\/jcpe.13642","journal-title":"J Clin Periodontol."},{"issue":"2","key":"713_CR62","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1007\/s00784-017-2325-6","volume":"22","author":"L Ramaglia","year":"2018","unstructured":"Ramaglia L, Guida A, Iorio-Siciliano V, Cuozzo A, Blasi A, Sculean A (2018) Stage-specific therapeutic strategies of medication-related osteonecrosis of the jaws: a systematic review and meta-analysis of the drug suspension protocol. Clin Oral Invest 22(2):597\u2013615. https:\/\/doi.org\/10.1007\/s00784-017-2325-6","journal-title":"Clin Oral Invest"},{"issue":"1","key":"713_CR63","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1038\/sj.ebd.6401287","volume":"19","author":"I Reynolds","year":"2018","unstructured":"Reynolds I, Duane B (2018) Periodontal disease has an impact on patients\u2019 quality of life: question: do periodontal diseases impact on quality of life? Evid Based Dent 19(1):14\u201315. https:\/\/doi.org\/10.1038\/sj.ebd.6401287","journal-title":"Evid Based Dent"},{"key":"713_CR64","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1185\/030079904125004475","volume":"20","author":"G Rodan","year":"2004","unstructured":"Rodan G, Reszka A, Golub E, Rizzoli R (2004) Bone safety of long-term bisphosphonate treatment. Curr Med Res Opin 20:1291\u20131300","journal-title":"Curr Med Res Opin"},{"key":"713_CR65","doi-asserted-by":"publisher","unstructured":"Ruggiero SL, Dodson TB, Aghaloo T, Carlson ER, Ward BB, Kademani D (2022) American Association of Oral and Maxillofacial Surgeons\u2019 position paper on medication-related osteonecrosis of the jaws\u20142022 update. J Oral Maxillofac Surg 80(5):920\u2013943. https:\/\/doi.org\/10.1016\/j.joms.2022.02.008","DOI":"10.1016\/j.joms.2022.02.008"},{"key":"713_CR66","doi-asserted-by":"publisher","unstructured":"Ruggiero SL, Dodson TB, Fantasia J, Goodday R, Aghaloo T, Mehrotra B, O\u2019Ryan F (2014) American Association of Oral and Maxillofacial Surgeons Position Paper on medication-related osteonecrosis of the jaw\u20142014 update. J Oral Maxillofac Surg 72(10):1938\u20131956. https:\/\/doi.org\/10.1016\/j.joms.2014.04.031","DOI":"10.1016\/j.joms.2014.04.031"},{"issue":"15","key":"713_CR67","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1056\/NEJMoa1708322","volume":"377","author":"KG Saag","year":"2017","unstructured":"Saag KG, Petersen J, Brandi ML, Karaplis AC, Lorentzon M, Thomas T, Grauer A (2017) Romosozumab or alendronate for fracture prevention in women with osteoporosis. N Engl J Med. 377(15):1417\u201327. https:\/\/doi.org\/10.1056\/NEJMoa1708322","journal-title":"N Engl J Med."},{"key":"713_CR68","doi-asserted-by":"publisher","unstructured":"Sanz M, Ceriello C, Buysschaert M, Chapple I, Demmer RT, Graziani F, Vegh D (2018) Scientific evidence on the links between periodontal diseases and diabetes: consensus report and guidelines of the Joint Workshop on Periodontal Diseases and Diabetes by the International Diabetes Federation and the European Federation of Periodontology. J Clin Periodontol 45(2):138\u201349. https:\/\/doi.org\/10.1111\/jcpe.12808","DOI":"10.1111\/jcpe.12808"},{"key":"713_CR69","doi-asserted-by":"publisher","unstructured":"Sanz M, Herrera D, Kebschull M, Chapple I, Jepsen S, Berglundh T, Wennstr\u00f6m J (2020) Treatment of stage I\u2013III periodontitis\u2014the EFP S3 level clinical practice guideline. J Clin Periodontol 47(S22):4\u201360. https:\/\/doi.org\/10.1111\/jcpe.13290","DOI":"10.1111\/jcpe.13290"},{"key":"713_CR70","doi-asserted-by":"publisher","unstructured":"Schiodt M, Otto S, Fedele S et al (2019) Workshop of European Task Force on Medication-Related Osteonecrosis of the Jaw\u2014current challenges. Oral Dis 25:1815\u20131821. https:\/\/doi.org\/10.1111\/odi.13160","DOI":"10.1111\/odi.13160"},{"key":"713_CR71","doi-asserted-by":"publisher","unstructured":"Seki K, Namaki S, Kamimoto A, Hagiwara Y (2021) Medication-related osteonecrosis of the jaw subsequent to peri-implantitis: a case report and literature review. J Oral Implantol 47(6):502\u2013510. https:\/\/doi.org\/10.1563\/aaid-joi-D-19-00385","DOI":"10.1563\/aaid-joi-D-19-00385"},{"issue":"1","key":"713_CR72","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00198-021-06095-y","volume":"33","author":"S Singh","year":"2022","unstructured":"Singh S, Dutta S, Khasbage S, Kumar T, Sachin J, Sharma J, Varthya SB (2022) A systematic review and meta-analysis of efficacy and safety of romosozumab in postmenopausal osteoporosis. Osteoporos Int 33(1):1\u201312. https:\/\/doi.org\/10.1007\/s00198-021-06095-y","journal-title":"Osteoporos Int"},{"issue":"3","key":"713_CR73","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1563\/aaid-joi-D-19-00351","volume":"47","author":"J Sher","year":"2021","unstructured":"Sher J, Kirkham-Ali K, Luo JD, Miller C, Sharma D (2021) Dental implant placement in patients with a history of medications related to osteonecrosis of the jaws: a systematic review. J Oral Implantol 47(3):249\u2013268. https:\/\/doi.org\/10.1563\/aaid-joi-D-19-00351","journal-title":"J Oral Implantol"},{"issue":"3","key":"713_CR74","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1177\/0022034517732770","volume":"97","author":"A Soundia","year":"2018","unstructured":"Soundia A, Hadaya D, Esfandi N, Gkouveris I, Christensen R, Dry SM, Tetradis S (2018) Zoledronate impairs socket healing after extraction of teeth with experimental periodontitis. J Dent Res. 97(3):312\u201320. https:\/\/doi.org\/10.1177\/0022034517732770","journal-title":"J Dent Res."},{"key":"713_CR75","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1111\/clr.13282","volume":"29","author":"A Stavropoulos","year":"2018","unstructured":"Stavropoulos A, Bertl K, Pietschmann P, Pandis N, Schi\u00f8dt M, Klinge B (2018) The effect of antiresorptive drugs on implant therapy: systematic review and meta-analysis. Clin Oral Implant Res 29:54\u201392. https:\/\/doi.org\/10.1111\/clr.13282","journal-title":"Clin Oral Implant Res"},{"issue":"12","key":"713_CR76","doi-asserted-by":"publisher","first-page":"793","DOI":"10.2165\/11594240-000000000-00000","volume":"50","author":"L Sutjandra","year":"2011","unstructured":"Sutjandra L, Rodriguez RD, Doshi S, Ma M, Peterson MC, Jang GR et al (2011) Population pharmacokinetic meta-analysis of denosumab in healthy subjects and postmenopausal women with osteopenia or osteoporosis. Clin Pharmacokinet 50(12):793\u2013807. https:\/\/doi.org\/10.2165\/11594240-000000000-00000","journal-title":"Clin Pharmacokinet"},{"issue":"7","key":"713_CR77","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1002\/JPER.19-0385","volume":"91","author":"N Taniguchi","year":"2020","unstructured":"Taniguchi N, Osaki M, Onuma K, Ishikawa M, Ryoke K, Kodani I, Okada F (2020) Bisphosphonate-induced reactive oxygen species inhibit proliferation and migration of oral fibroblasts: a pathogenesis of bisphosphonate-related osteonecrosis of the Jaw. J Periodontol 91(7):947\u2013955. https:\/\/doi.org\/10.1002\/JPER.19-0385","journal-title":"J Periodontol"},{"key":"713_CR78","doi-asserted-by":"publisher","unstructured":"Tarantino U, Iolascon G, Cianferotti L, Masi L, Marcucci G, Giusti F, Brandi ML (2017) Clinical guidelines for the prevention and treatment of osteoporosis: summary statements and recommendations from the Italian Society for Orthopaedics and Traumatology. J Orthop Traumatol. 18(S1):3\u201336. https:\/\/doi.org\/10.1007\/s10195-017-0474-7","DOI":"10.1007\/s10195-017-0474-7"},{"key":"713_CR79","doi-asserted-by":"publisher","unstructured":"Taylor KH, Middlefell LS, Mizen KD (2010) Osteonecrosis of the jaws induced by anti-RANK ligand therapy. Br J Oral Maxillofacial Surg 48(3):221\u2013223. https:\/\/doi.org\/10.1016\/j.bjoms.2009.08.030","DOI":"10.1016\/j.bjoms.2009.08.030"},{"key":"713_CR80","doi-asserted-by":"publisher","first-page":"S159","DOI":"10.1002\/JPER.18-0006","volume":"89","author":"MS Tonetti","year":"2018","unstructured":"Tonetti MS, Greenwell H, Kornman KS (2018) Staging and grading of periodontitis: framework and proposal of a new classification and case definition. J Periodontol 89:S159\u2013S172. https:\/\/doi.org\/10.1002\/JPER.18-0006","journal-title":"J Periodontol"},{"key":"713_CR81","doi-asserted-by":"publisher","unstructured":"Tsourdi E, Langdahl B, Cohen-Solal M, Aubry-Rozier B, Eriksen EF, Gua\u00f1abens N, Obermayer-Pietsch B, Ralston SH, Eastell R, Zillikens MC (2017) Discontinuation of Denosumab therapy for osteoporosis: a systematic review and position statement by ECTS. Bone 105:11\u201317. https:\/\/doi.org\/10.1016\/j.bone.2017.08.003","DOI":"10.1016\/j.bone.2017.08.003"},{"key":"713_CR82","doi-asserted-by":"publisher","unstructured":"Vallina C, Ramirez L, Torres J, Casanas E, Hernandez G, Lopez-Pintor RM (2019) Osteonecrosis of the jaws produced by Sunitinib: a systematic review. Med Oral Patol Oral Cir Bucal 24(3):e326\u2013e338. https:\/\/doi.org\/10.4317\/medoral.22858","DOI":"10.4317\/medoral.22858"},{"issue":"6","key":"713_CR83","doi-asserted-by":"publisher","first-page":"2443","DOI":"10.1210\/jc.2018-01965","volume":"104","author":"NB Watts","year":"2019","unstructured":"Watts NB, Grbic JT, Binkley N, Papapoulos S, Butler PW, Yin X, McClung M (2019) Invasive oral procedures and events in postmenopausal women with osteoporosis treated with denosumab for up to 10 years. J Clin Endocrinol Metab 104(6):2443\u201352. https:\/\/doi.org\/10.1210\/jc.2018-01965","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"713_CR84","doi-asserted-by":"publisher","first-page":"2043","DOI":"10.1124\/dmd.108.021071","volume":"36","author":"HM Weiss","year":"2008","unstructured":"Weiss HM, Pfaar U, Schweitzer A, Wiegand H, Skerjanec A, Schran H (2008) Biodistribution and plasma protein binding of zoledronic acid. Drug Metab Dispos. 36(10):2043\u20139. https:\/\/doi.org\/10.1124\/dmd.108.021071","journal-title":"Drug Metab Dispos."},{"key":"713_CR85","doi-asserted-by":"publisher","unstructured":"Wong RMY, Cheung W-H, Chow SKH, Ng RWK, Li W, Hsu AY-C, Law SW (2022) Recommendations on the post-acute management of the osteoporotic fracture\u2014patients with \u2018very-high\u2019 re-fracture risk. J Orthopaedic Transl 37:94\u201399. https:\/\/doi.org\/10.1016\/j.jot.2022.09.010","DOI":"10.1016\/j.jot.2022.09.010"},{"issue":"2","key":"713_CR86","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1111\/odi.13531","volume":"27","author":"S Xu","year":"2021","unstructured":"Xu S, Zhang G, Guo J-F, Tan Y-H (2021) Associations between osteoporosis and risk of periodontitis: a pooled analysis of observational studies. Oral Dis 27(2):357\u2013369. https:\/\/doi.org\/10.1111\/odi.13531","journal-title":"Oral Dis"},{"issue":"4","key":"713_CR87","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1016\/j.identj.2020.12.005","volume":"71","author":"M Yamori","year":"2021","unstructured":"Yamori M, Tamura M, Mikami M, Mori T, Noi M, Machida Y, Yamamoto G (2021) Differences in the knowledge and experience of physicians and dentists about medication-related osteonecrosis of the jaw in osteoporotic patients. Int Dental J. 71(4):336\u201342. https:\/\/doi.org\/10.1016\/j.identj.2020.12.005","journal-title":"Int Dental J."},{"issue":"25","key":"713_CR88","doi-asserted-by":"publisher","first-page":"2270","DOI":"10.1200\/JCO.19.01186","volume":"37","author":"N Yarom","year":"2019","unstructured":"Yarom N, Shapiro CL, Peterson DE, Van Poznak CH, Bohlke K, Ruggiero SL, Saunders DP (2019) Medication-related osteonecrosis of the jaw: MASCC\/ISOO\/ASCO clinical practice guideline. J Clin Oncol. 37(25):2270\u201390. https:\/\/doi.org\/10.1200\/JCO.19.01186","journal-title":"J Clin Oncol."},{"key":"713_CR89","doi-asserted-by":"publisher","unstructured":"Yu B, Wang C-Y (2022) Osteoporosis and periodontal diseases\u2014an update on their association and mechanistic links. Periodontology 200 89(1):99\u2013113. https:\/\/doi.org\/10.1111\/prd.12422","DOI":"10.1111\/prd.12422"},{"key":"713_CR90","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1097\/BOT.0b013e31828e13fe","volume":"28","author":"D Zhang","year":"2014","unstructured":"Zhang D, Potty A, Vyas P, Lane J (2014) The role of recombinant PTH in human fracture healing: a systematic review. J Orthop Trauma 28:57\u201362","journal-title":"J Orthop Trauma"},{"issue":"21","key":"713_CR91","doi-asserted-by":"publisher","first-page":"3380","DOI":"10.3390\/cells11213380","volume":"11","author":"L Zhu","year":"2022","unstructured":"Zhu L, Zhou C, Chen S, Huang D, Jiang Y, Lan Y, Li Y (2022) Osteoporosis and alveolar bone health in periodontitis niche: a predisposing factors-centered review. Cells 11(21):3380. https:\/\/doi.org\/10.3390\/cells11213380","journal-title":"Cells"},{"key":"713_CR92","doi-asserted-by":"publisher","unstructured":"Zito S, Fortinguerra F, Pierantozzi A, Ambrosino F, Traversa G, Trotta F, Da Cas R, Cangini A (2021) L\u2019uso dei farmaci in Italia. Il Rapporto Nazionale OsMed 2020 [Medicines use in Italy. 2020 OsMed National Report]. Recenti Prog Med. 112(10):659\u201367. Italian. https:\/\/doi.org\/10.1701\/3679.36657","DOI":"10.1701\/3679.36657"}],"container-title":["Journal of Orthopaedics and Traumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10195-023-00713-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s10195-023-00713-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10195-023-00713-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,15]],"date-time":"2023-07-15T17:01:47Z","timestamp":1689440507000},"score":1,"resource":{"primary":{"URL":"https:\/\/jorthoptraumatol.springeropen.com\/articles\/10.1186\/s10195-023-00713-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,15]]},"references-count":92,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["713"],"URL":"https:\/\/doi.org\/10.1186\/s10195-023-00713-7","relation":{},"ISSN":["1590-9999"],"issn-type":[{"value":"1590-9999","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,15]]},"assertion":[{"value":"8 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All the authors gave their consent for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"L. Landi: Nothing to disclose. P. Tranquilli Leali: Nothing to disclose. L. Barbato: Nothing to disclose. A.M. Carrassi: Nothing to disclose. N. Discepoli: Nothing to disclose. P.C.M. Muti: Nothing to disclose. G. Oteri: Nothing to disclose. M. Rigoni: Nothing to disclose. E. Romanini: Nothing to disclose. C. Ruggiero: Nothing to disclose. U. Tarantino: Nothing to disclose. E. Varoni: Nothing to disclose. N.M. Sforza: Nothing to disclose. M.L. Brandi: Honoraria: Amgen, Bruno Farmaceutici, Calcilytix, Kyowa Kirin, UCB; grants and\/or speaker: Abiogen, Alexion, Amgen, Amolyt, Amorphical, Bruno Farmaceutici, CoGeDi, Echolight, Eli Lilly, Enterabio, Gedeon Richter, Italfarmaco, Kyowa Kirin, Menarini, Monte Rosa, SPA, Takeda, Theramex, UCB; consultant: Aboca, Alexion, Amolyt, Bruno Farmaceutici, Calcilytix, Echolight, Kyowa Kirin, Personal Genomics, UCB.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"36"}}